tert-Butyl 2-(3-fluorophenyl)propan-2-ylcarbamate, 95.0%, 1g

H-Hyp(tBu)-OtBu.HCl, 95+%, 1g

2-methyl-4H-furo[3,2-b]pyrrole-5-carboxylic acid, 95.0%, 2g

4-(dimethylamino)-3-(trifluoromethyl)benzonitrile, 10g

(R)-3-(6-Ethoxy-pyrimidin-4-ylamino)-pyrrolidine-1-carboxylic acid tert-butyl ester, 95.0%, 100mg

Fluorescin [Reagent for Oxydases and Peroxydases]>95.0%(GC)25g

2-Chloro-5-methylthiazole-4-carbaldehyde, 98%, 250mg

(2S,3S,4S,5R)-2,3,4,5-Tetrahydroxy-6-oxohexanoic acid, 95.0%, 250g

Microliter syringe GASTIGHT® series 1000, 1.0 ml, 1001 TLL, 1 piece

N-BOC-N-METHYL-1,4-DIOXASPIRO[4.5]DECAN-8-AMINE, 95.0%, 1g

(cis-2-((1H-1,2,4-triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl methanesulfonate, 99.0%, 25g

2,4-DIFLUOROBENZENE-1,3-DIOL, 95.0%, 250mg

Ethyl 4-iso-propylbenzoylformate, 96.0%, 5g